A Study on Prognostic Value of Cellular Immunological Indicators in Omicron Variant Infected Elderly Severe Patients

Jiefu TANG; Dexing YANG; Shengzhe LIU; Qiang WANG; Kai FU; Zhenfang WANG; Ying LUAN; Min LI; Rong LIU

doi:10.12259/j.issn.2095-610X.S20231214

Volume 44 Issue 12

Dec. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2023 > 44(12): 87-94

Jiefu TANG, Dexing YANG, Shengzhe LIU, Qiang WANG, Kai FU, Zhenfang WANG, Ying LUAN, Min LI, Rong LIU. A Study on Prognostic Value of Cellular Immunological Indicators in Omicron Variant Infected Elderly Severe Patients[J]. Journal of Kunming Medical University, 2023, 44(12): 87-94. doi: 10.12259/j.issn.2095-610X.S20231214

Citation:

Jiefu TANG, Dexing YANG, Shengzhe LIU, Qiang WANG, Kai FU, Zhenfang WANG, Ying LUAN, Min LI, Rong LIU. A Study on Prognostic Value of Cellular Immunological Indicators in Omicron Variant Infected Elderly Severe Patients[J]. Journal of Kunming Medical University, 2023, 44(12): 87-94. doi: 10.12259/j.issn.2095-610X.S20231214

Citation:

Jiefu TANG, Dexing YANG, Shengzhe LIU, Qiang WANG, Kai FU, Zhenfang WANG, Ying LUAN, Min LI, Rong LIU. A Study on Prognostic Value of Cellular Immunological Indicators in Omicron Variant Infected Elderly Severe Patients[J]. Journal of Kunming Medical University, 2023, 44(12): 87-94. doi: 10.12259/j.issn.2095-610X.S20231214

PDF( 784 KB)

A Study on Prognostic Value of Cellular Immunological Indicators in Omicron Variant Infected Elderly Severe Patients

doi: 10.12259/j.issn.2095-610X.S20231214

1.
Geriatric ICU，The 1st Affiliated Hospital of Kunming Medical University，Yunnan Kunming 650032
2.
Dept. of Emergency Internal Medicine，The 1st People's Hospital of Yunnan Province，Yunnan Kunming 650034，China

Received Date: 2023-09-13
Publish Date: 2023-12-25

Abstract

Abstract

Objective To investigate the characteristics of clinical cellular immunity and its relationship with prognosis in elderly patients with severe infection caused by Omicron variant. Methods The clinical data of 53 patients with Omicron variant infection admitted to the geriatric Intensive Care Unit of the First Affiliated Hospital of Kunming Medical University from December 2022 to February 2023 were retrospectively analyzed. The patients were divided into 22 survival cases and 31 death cases for comparison between the two groups. Logistic analysis is adopted to define the omicron variants of elderly severe infections prognostic factors and construct the ROC curve. Results Multivariate logistic analysis revealed that the independent risk factors were elevated IL-6（P = 0.043） and decreased absolute T lymphocyte count（P = 0.011）.AUC value of ROC of IL-6, absolute T lymphocyte count and IL-6 combined with absolute T lymphocyte count was 0.818, 0.796 and 0.887. Conclusion Elevated IL-6 and decreased absolute T lymphocyte count are independent risk factors for elderly severe patients with Omicron variant infections.
- Omicron variant,
- Prognosis,
- Cellular immunological indicators

FullText(HTML)

References(35)

References

[1]	World Health Organization . WHO Coronavirus （COVID-19） Dashboard[EB/OL]. (2023-03-09)[2023-03-09]https://covid19.who.int./
[2]	中国疾病预防控制中心[EB/OL]. (2023-03-18)[2023-0326]https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202303/t20230318_264368.html.
[3]	Yang X,Yu Y,Xu J,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan,China: A single-centered,retrospective,observational study[J]. The Lancet. Respiratory Medicine,Lancet Respir Med,2020,8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5
[4]	Zhang J,Dong X,Liu G,et al. Risk and protective factors for COVID-19 morbidity,severity,and mortality[J]. Clinical Reviews in Allergy & Immunology,2023,64(1):90-107.
[5]	彭丁,杨爽,李邦一,等. 老年重症及危重症新型冠状病毒感染患者预后的危险因素分析[J]. 中华老年多器官疾病杂志,2021,20(8):600-603.
[6]	Ke H,Chang M R,Marasco W A. Immune evasion of SARS-CoV-2 Omicron subvariants[J]. Vaccines,2022,10(9):1545. doi: 10.3390/vaccines10091545
[7]	Kumar S,Thambiraja T S,Karuppanan K,et al. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein[J]. Journal of Medical Virology,2022,94(4):1641-1649. doi: 10.1002/jmv.27526
[8]	Aouissi H A. Algeria’s preparedness for Omicron variant and for the fourth wave of COVID-19[J]. Global Health & Medicine,2021,3(6):413-414.
[9]	中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版)[J]. 中国合理用药探索,2023,20(1):1-11.
[10]	Assmann-Wischer U,Simon M M,Lehmann-Grube F. Mechanism of recovery from acute virus infection. III. Subclass of T lymphocytes mediating clearance of lymphocytic choriomeningitis virus from the spleens of mice[J]. Medical Microbiology and Immunology,1985,174(5):249-256. doi: 10.1007/BF02124809
[11]	廖宝林,施海燕,刘艳霞,等. 新型冠状病毒肺炎患者早期外周血淋巴细胞亚群及细胞因子特征[J]. 中华实验和临床感染病杂志(电子版),2021,15(3):182-188.
[12]	Moss P. The T cell immune response against SARS-CoV-2[J]. Nature Immunology,2022,23(2):186-193. doi: 10.1038/s41590-021-01122-w
[13]	Chen G,Wu D,Guo W,et al. Clinical and immunological features of severe and moderate coronavirus disease 2019[J]. The Journal of Clinical Investigation,2020,130(5):2620-2629. doi: 10.1172/JCI137244
[14]	Zheng M,Gao Y,Wang G,et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients[J]. Cellular & Molecular Immunology,2020,17(5):533-535.
[15]	He S,Fang Y,Yang J,et al. Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients[J]. Frontiers in Public Health,2022,10:1032957. doi: 10.3389/fpubh.2022.1032957
[16]	Chu H,Zhou J,Wong B H,et al. Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways[J]. The Journal of Infectious Diseases,2016,213(6):904-914. doi: 10.1093/infdis/jiv380
[17]	Ren X,Wen W,Fan X,et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas[J]. Cell,2021,184(7):1895-1913.e19. doi: 10.1016/j.cell.2021.01.053
[18]	Delorey T M,Ziegler C G K,Heimberg G,et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets[J]. Nature,2021,595(7865):107-113. doi: 10.1038/s41586-021-03570-8
[19]	Shen X R,Geng R,Li Q,et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2[J]. Signal Transduction and Targeted Therapy,2022,7(1):83. doi: 10.1038/s41392-022-00919-x
[20]	Mukherjee A G,Wanjari U R,Murali R,et al. Omicron variant infection and the associated immunological scenario[J]. Immunobiology,Elsevier,2022,227(3):152222.
[21]	Akkız H. The biological functions and clinical significance of SARS-CoV-2 variants of corcern[J]. Frontiers in Medicine,2022,9:849217. doi: 10.3389/fmed.2022.849217
[22]	Nuutila J. The novel applications of the quantitative analysis of neutrophil cell surface FcgammaRI (CD64) to the diagnosis of infectious and inflammatory diseases[J]. Current Opinion in Infectious Diseases,2010,23(3):268-274. doi: 10.1097/QCO.0b013e32833939b0
[23]	Dimoula A,Pradier O,Kassengera Z,et al. Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients[J]. Clinical Infectious Diseases:An Official Publication of the Infectious Diseases Society of America,2014,58(6):820-829. doi: 10.1093/cid/cit936
[24]	Hoffmann J,Etati R,Brendel C,et al. The low expression of Fc-Gamma receptor III (CD16) and high expression of Fc-Gamma Receptor I (CD64) on neutrophil granulocytes mark severe COVID-19 pneumonia[J]. Diagnostics,2022,12(8):2010. doi: 10.3390/diagnostics12082010
[25]	Benlyamani I,Venet F,Coudereau R,et al. Monocyte HLA-DR measurement by flow cytometry in COVID-19 patients: An interim review[J]. Cytometry. Part A:The Journal of the International Society for Analytical Cytology,2020,97(12):1217-1221. doi: 10.1002/cyto.a.24249
[26]	Venet F,Demaret J,Gossez M,et al. Myeloid cells in sepsis-acquired immunodeficiency[J]. Annals of the New York Academy of Sciences,2021,1499(1):3-17. doi: 10.1111/nyas.14333
[27]	Galbraith N,Walker S,Carter J,et al. Past,present,and future of augmentation of monocyte function in the surgical patient[J]. Surgical Infections,2016,17(5):563-569. doi: 10.1089/sur.2016.014
[28]	王强,杨德兴,周维钰,等. 基于循环和细胞免疫效应指标为基础的脓毒性休克患者预后风险因素分析[J]. 昆明医科大学学报,2023,44(7):78-87.
[29]	Li T,Lu H,Zhang W. Clinical observation and management of COVID-19 patients[J]. Emerging Microbes & Infections,2020,9(1):687-690.
[30]	王宇航,蔡芸,梁蓓蓓,等. COVID-19细胞因子风暴的预警与治疗进展[J]. 中国新药杂志,2020,29(13):1514-1519.
[31]	Shimabukuro-Vornhagen A,Gödel P,Subklewe M,et al. Cytokine release syndrome[J]. Journal for Immunotherapy of Cancer,2018,6:56. doi: 10.1186/s40425-018-0343-9
[32]	Cummings M J,Baldwin M R,Abrams D,et al. Epidemiology,clinical course,and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study[J]. Lancet (London,England),2020,395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2
[33]	Chen R,Sang L,Jiang M,et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China[J]. The Journal of Allergy and Clinical Immunology,Elsevier,2020,146(1):89. doi: 10.1016/j.jaci.2020.05.003
[34]	樊菡,王莉,王晓,等. 老年新型冠状病毒肺炎患者的临床特征[J]. 中国老年学杂志,2021,41(7):1414-1417.
[35]	Uciechowski P,Dempke W C M. Interleukin-6: A masterplayer in the cytokine network[J]. Oncology,2020,98(3):131-137. doi: 10.1159/000505099

Relative Articles(20)

Relative Articles

[1]	Ying ZHANG, Xiangru LUO, Xing WANG, Pan ZHAO, Kun LIAN, Yuanqin LI, Mingkun SHAO. Analysis on the Expression of Basement Membrane Protein in Endometrial Carcinoma and its Relationship with Immune Invasion. Journal of Kunming Medical University, 2024, 46(): 1-10.
[2]	Shuaiqiang WANG, Kejin TONG, Shuofeng ZHANG. Effect of Compound Probiotic Powder on Immune Function of Mice. Journal of Kunming Medical University, 2024, 45(10): 29-35. doi: 10.12259/j.issn.2095-610X.S20241005
[3]	Ruiting ZHANG, Bin YAN, Zuyan LI, Jinmin SUN, Jin YAO. Relations between Peripheral Blood Blast Clearance Time and Albumin Level at Initial Diagnosis during Induction Chemotherapy and Genetic Mutations and Prognosis in Patients with Acute Myeloid Leukemia. Journal of Kunming Medical University, 2024, 45(8): 117-124. doi: 10.12259/j.issn.2095-610X.S20240817
[4]	Chunyan LIU, Bingqing CHANG, Chao LI, Xin REN, Xiaoqin LIU. The Relationship between T Lymphocyte Subsets and Pathological Characteristics of Acute Myeloid Leukemia and the Value of Predicting Chemotherapy Prognosis. Journal of Kunming Medical University, 2024, 45(5): 116-122. doi: 10.12259/j.issn.2095-610X.S20240518
[5]	Qi NIE, Li LIU, Yue TIAN, Xiaoyan MAO, Qulian GUO, Xin TIAN. Abnormal Clinical Features and Prognosis of ACTH in Pediatric Acute B Lymphocytic Leukemia. Journal of Kunming Medical University, 2024, 45(10): 75-84. doi: 10.12259/j.issn.2095-610X.S20241012
[6]	Lizhu ZHAO, Ying DONG, Yue DENG, Lihua YANG. Correlation between Epithelial Cell Related Genes and Prognosis of Patients with Ovarian Cancer based on Single Cell Sequencing. Journal of Kunming Medical University, 2024, 45(4): 9-16. doi: 10.12259/j.issn.2095-610X.S20240402
[7]	Xinyi MEN, Jing ZHAO, Yongchun SHEN, Hui JI, Xiuxia WANG. The Relationship between Peripheral Blood Immunoglobulin，Erythrocyte Sedimentation Rate，Homocysteine and the Degree of Central Nervous System Vasculitis in Children and Their Influence on Prognosis. Journal of Kunming Medical University, 2024, 45(12): 1-7.
[8]	Jiadai TANG, Jing YANG, Hongli SONG, Jiaojiao CHEN, Zhonghui MIAO, Lin XIE. Correlation of Metastatic and Prognostic Factors in 318 Cases of Primary Gastric Cancer. Journal of Kunming Medical University, 2023, 44(2): 75-87. doi: 10.12259/j.issn.2095-610X.S20230218
[9]	Ting GAO, Sheng HUANG, Rong GUO, Dedian CHEN. Clinicopathological Features and Prognosis of Mucinous Breast Carcinoma. Journal of Kunming Medical University, 2023, 44(3): 54-60. doi: 10.12259/j.issn.2095-610X.S20230306
[10]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[11]	Qiang WANG, Dexing YANG, Weiyu ZHOU, Jiefu TANG, Kai FU, Zhenfang WANG, Shengzhe LIU, Min LI, Ying LUAN, Rong LIU. Analysis of Prognostic Risk Factors in Patients with Septic Shock Based on Circulatory and Cellular Immune Response Indicators. Journal of Kunming Medical University, 2023, 44(7): 78-87. doi: 10.12259/j.issn.2095-610X.S20230716
[12]	Changmeng HU, Lin WU. Correlation Between Silva Type and Prognosis of Cervical HPV-associated Adenocarcinoma. Journal of Kunming Medical University, 2022, 43(8): 113-121. doi: 10.12259/j.issn.2095-610X.S20220817
[13]	Shizhou LI, Xiaoguang HE, Yan LIN, Yuxiao LI, Xi YANG, Xiaoyu WANG, Shenghao YANG. Clinical Analysis of Cervical Lymph Node Metastatic Squamous Cell Carcinoma of Unknown Primary Site. Journal of Kunming Medical University, 2022, 43(7): 80-85. doi: 10.12259/j.issn.2095-610X.S20220710
[14]	Yan-hong LIU, Xiang-yue ZHAO, Qing-xin XIE, Meng-di PU, Wei-dong LU. Influence of DC-Chol Cationic Liposome Adjuvant on the Immune Effect of Tetravalent Influenza Vaccine. Journal of Kunming Medical University, 2021, 42(3): 1-4. doi: 10.12259/j.issn.2095-610X.S20210302
[15]	Feng Zi Hao . Clinical Efficacy of Laparoscopic Operation Combined with Dexamethasone Cavity Flushing in Endometriosis. Journal of Kunming Medical University,
[16]	Zhang Ai Ling . Conventional Segmentation and Large Fractionated Three-dimensional Conformal Radiotherapy in the Treatment of Non Small Cell Lung Cancer with Superior Vena Cava Syndrome. Journal of Kunming Medical University,
[17]	Nie Bo . Clinical Characteristic of 34 Patients with Extranodal Nasal Type NK/T-Cell Lymphoma. Journal of Kunming Medical University,
[18]	Liu Ju Peng . . Journal of Kunming Medical University,
[19]	Shi Lei . . Journal of Kunming Medical University,
[20]	Cun Xin Hua . . Journal of Kunming Medical University,